Patents by Inventor Angelo Pizzoni

Angelo Pizzoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMBINATION BASED ON RIFAXIMIN AND PROBIOTIC YEASTS, COMPOSITIONS CONTAINING IT AND THEIR USE IN THERAPY
    Publication number: 20260183356
    Abstract: The present invention relates to a novel combination of rifaximin and probiotic yeast, the pharmaceutical compositions containing the combination as well as their use in therapy, in particular in the prevention and/or treatment of intestinal diseases.
    Type: Application
    Filed: November 28, 2023
    Publication date: July 2, 2026
    Applicant: NYUMA PHARMA SRL
    Inventors: Angelo Pizzoni, Paolo Pizzoni
  • NOVEL COMBINATION BASED ON SALIFIED BUTYRIC AND AND YEASTS, COMPOSITIONS CONTAINING IT AND THEIR USE IN THERAPY
    Publication number: 20250352499
    Abstract: The present invention relates to a novel combination of salified butyric acid and yeast, the pharmaceutical and nutraceutical compositions containing the combination as well as their use in the prevention and treatment of intestinal diseases.
    Type: Application
    Filed: June 14, 2023
    Publication date: November 20, 2025
    Applicant: NYUMA PHARMA SRL
    Inventors: Angelo Pizzoni, Paolo Pizzoni
  • Combination of glycosaminoglycans and an antacid agent and compositions thereof
    Patent number: 11116786
    Abstract: The present invention refers to a combination of hyaluronic acid, chondroitin sulfate in combination with at least one antacid agent, in particular magaldrate, for the prevention or treatment of gastric hyperacidity and gastroesophageal reflux and related pathologies thereof. More particularly, the combination is used for the preparation of oral compositions with at least one pharmaceutical carrier and advantageously that comprise a bioadhesive agent as well.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: September 14, 2021
    Assignee: APHARM S.R.L.
    Inventors: Angelo Pizzoni, Paolo Pizzoni
  • Combination of hyaluronic acid and macrogol and pharmaceutical compositions containing it
    Patent number: 10471092
    Abstract: The invention relates to a new combination of hyaluronic acid and macrogol, pharmaceutical compositions containing said combination and the use of the combination and compositions as laxatives.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: November 12, 2019
    Assignee: APHARM S.r.l.
    Inventor: Angelo Pizzoni
  • Combination of glycosaminoglycans and an antacid agent and compositions thereof
    Publication number: 20180280426
    Abstract: The present invention refers to a combination of hyaluronic acid, chondroitin sulfate in combination with at least one antacid agent, in particular magaldrate, for the prevention or treatment of gastric hyperacidity and gastroesophageal reflux and related pathologies thereof. More particularly, the combination is used for the preparation of oral compositions with at least one pharmaceutical carrier and advantageously that comprise a bioadhesive agent as well.
    Type: Application
    Filed: September 30, 2016
    Publication date: October 4, 2018
    Inventors: Angelo PIZZONI, Paolo PIZZONI
  • Combination of glycosaminoglycans and cyclodextrins
    Patent number: 9974803
    Abstract: The invention relates to an injectable combination of two specific glycosaminoglycans, hyaluronic acid and chondroitin sulfate, with cyclodextrins and the use of the combination for the treatment of diseases related to the skeletal systems, particularly in the intra-articular treatment, as well as in the intradermal treatment.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: May 22, 2018
    Assignee: APHARM S.R.L.
    Inventors: Angelo Pizzoni, Paolo Pizzoni
  • COMBINATION OF HYALURONIC ACID AND MACROGOL AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
    Publication number: 20180008626
    Abstract: The invention relates to a new combination of hyaluronic acid and macrogol, pharmaceutical compositions containing said combination and the use of the combination and compositions as laxatives.
    Type: Application
    Filed: November 3, 2015
    Publication date: January 11, 2018
    Inventor: Angelo PIZZONI
  • COMBINATION OF GLYCOSAMINOGLYCANS AND CYCLODEXTRINS
    Publication number: 20170035799
    Abstract: The invention relates to an injectable combination of two specific glycosaminoglycans, hyaluronic acid and chondroitin sulfate, with cyclodextrins and the use of the combination for the treatment of diseases related to the skeletal systems, particularly in the intra-articular treatment, as well as in the intradermal treatment.
    Type: Application
    Filed: December 15, 2014
    Publication date: February 9, 2017
    Inventors: Angelo PIZZONI, Paolo PIZZONI
  • Glycosaminoglycan oral use and compositions
    Patent number: 9241953
    Abstract: The present invention concerns the use of a glycosaminoglycan association of hyaluronic acid and chondroitin sulfate for the preparation of oral compositions for the prevention or for the treatment of upper gastro-intestinal tract disorders and for the preparation of upper gastro-intestinal epithelial damage, as well as the oral compositions comprising said glycosaminoglycan association.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: January 26, 2016
    Assignee: APHARM S.R.L.
    Inventor: Angelo Pizzoni
  • Glycosaminoglycan oral use and compositions
    Patent number: 8735373
    Abstract: The present invention concerns the use of a glycosaminoglycan association of hyaluronic acid and chondroitin sulfate for the preparation of oral compositions for the prevention or for the treatment of upper gastro-intestinal tract disorders and for the preparation of upper gastro-intestinal epithelial damage, as well as the oral compositions comprising said glycosaminoglycan association.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: May 27, 2014
    Assignee: Apharm S.R.L.
    Inventor: Angelo Pizzoni
  • GLYCOSAMINOGLYCAN ORAL USE AND COMPOSITIONS
    Publication number: 20140107064
    Abstract: The present invention concerns the use of a glycosaminoglycan association of hyaluronic acid and chondroitin sulfate for the preparation of oral compositions for the prevention or for the treatment of upper gastro-intestinal tract disorders and for the preparation of upper gastro-intestinal epithelial damage, as well as the oral compositions comprising said glycosaminoglycan association.
    Type: Application
    Filed: December 20, 2013
    Publication date: April 17, 2014
    Applicant: APHARM S.R.L.
    Inventor: Angelo PIZZONI
  • GLYCOSAMINOGLYCAN ORAL USE AND COMPOSITIONS
    Publication number: 20110071106
    Abstract: The present invention concerns the use of a glycosaminoglycan association of hyaluronic acid and chondroitin sulfate for the preparation of oral compositions for the prevention or for the treatment of upper gastro-intestinal tract disorders and for the preparation of upper gastro-intestinal epithelial damage, as well as the oral compositions comprising said glycosaminoglycan association.
    Type: Application
    Filed: May 8, 2009
    Publication date: March 24, 2011
    Inventor: Angelo Pizzoni